Adjuvanttihoitoa

Adjuvanttihoito (English: Adjuvant therapy) refers to the use of additional treatments in conjunction with the primary treatment of a disease to improve the effectiveness of the treatment. This approach is commonly used in the treatment of various types of cancer, particularly in the postoperative period.

The concept of adjuvanttihoito originated in the 1960s, when it was first used in the treatment of breast cancer. Since then, it has become a standard practice in the treatment of numerous types of cancer, including colorectal cancer, lung cancer, and melanoma.

Adjuvanttihoito can take various forms, including chemotherapy, hormone therapy, targeted therapy, and immunotherapy. These treatments are intended to target and eliminate any remaining cancer cells that may have been left behind after primary treatment, thereby reducing the likelihood of cancer recurrence.

The goals of adjuvanttihoito include improving survival rates, reducing the risk of cancer recurrence, and increasing the overall quality of life of patients. These treatments are typically administered for a specific period after primary treatment, and the duration of treatment varies depending on the type and stage of the cancer.

The decision to undergo adjuvanttihoito is typically made in consultation with a healthcare team, taking into account the individual's overall health, medical history, and prognosis. Patients should discuss the potential benefits and risks of adjuvanttihoito with their healthcare provider and determine whether it is an appropriate course of treatment for their specific condition.